Svenja Maschke

Svenja Maschke

Auto-generated profile, based on publicly available information

Svenja Maschke

Medical School of St. Gallen, HOCH Health Ostschweiz, St.Gallen, Switzerland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2025 in Neurosurgical Review
Verified
Journal Article
Closed access
PDF file
VKVincens Kälin
Vincens Kälin
SMSvenja Maschke
Svenja Maschke
MGMenno R. Germans
Menno R. Germans
PBPhilippe Bijlenga
Philippe Bijlenga
RMRodolfo Maduri
Rodolfo Maduri
Isabel HostettlerIsabel Hostettler
Isabel Hostettler

23 December 2025 in Computers in Biology and Medicine
Verified
Journal Article
Open access
MDMatteo Delucchi
Matteo Delucchi
PBPhilippe Bijlenga
Philippe Bijlenga
Sandrine MorelSandrine Morel
Sandrine Morel
RFReinhard Furrer
Reinhard Furrer
Isabel HostettlerIsabel Hostettler
Isabel Hostettler
GSGeorg Ralph Spinner
Georg Ralph Spinner
Multicenter clinical datasets are increasingly available but are often analyzed using models that ignore center-specific variability or fail to capture complex dependencies among variables. This is particularly limiting in the context of intracranial aneurysms (IAs), where existing risk scores lack precision and interpretability. We apply mixed-effects additive Bayesian networks (ABNs) to a large multicenter dataset to model interdependencies among demographic, clinical, and aneurysm-specific features in solitary ruptured IAs, while accounting for heterogeneity across study centers. Data from seven European centers were subsequently harmonized into an observational, cross-sectional cohort of patients with solitary ruptured IAs to mitigate selection bias inherent in cohorts with incidentally discovered unruptured IAs. Mixed-effects ABNs modeled probabilistic dependencies using generalized linear models with random intercepts for study centers. Structure learning was performed via structural Markov chain Monte Carlo sampling with Bayesian information criterion scoring. Model performance was assessed using graphical comparison, intraclass correlation coefficients (ICCs), and predictive metrics. The mixed-effects ABN produced a more parsimonious network than the pooled model and better captured center-specific variation, particularly for variables with high ICCs (e.g., family history: ICC = 0.369). It also outperformed the pooled ABN in predicting family history (Area Under the Curve = 0.694 vs. 0.585) while yielding clinically interpretable associations, such as the influence of sex, smoking, and IA location on IA size. This application of mixed-effects ABNs reveals that accounting for inter-center heterogeneity is critical for accurately modeling risk factor dependencies in multicenter IA cohorts. This approach yields a more parsimonious network structure by reducing spurious associations found in pooled models. By disentangling patient-level effects from center-specific variations, the model enhances predictive power for heterogeneous variables and provides more reliable, clinically interpretable insights into IA pathophysiology, advancing the potential for personalized risk assessment.